More than 50% of men over the age of 50 suffer from benign prostatic hyperplasia, also known as an enlarged prostate. While BPH is common for older men, causing the frequent urge to urinate — ...
UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in men. The procedure uses tiny implants to lift and hold the enlarged prostate ...
WAYNE, Pa., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that the U.S. Food and Drug Administration (FDA) has granted the company an expanded indication for the ...
Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...
NICE commissioned an external assessment centre (EAC) to review the evidence submitted by the company. This section summarises that review. Full details of all the evidence are in the project ...
ALLENTOWN, Pa., Oct. 30, 2018 /PRNewswire-PRWeb/ -- Lehigh Valley Health Network today announced that Dr. Clifford Georges has been designated as a UroLift® Center of Excellence. The designation ...
NeoTract, a wholly owned subsidiary of Teleflex Incorporated TFX focused on addressing unmet needs in the field of urology, today announced that Michael Brame, M.D., Carolina Urology Partners in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback